Entry Detail



General Information

Database ID:exR0087355
RNA Name:hsa-miR-24-3p
RNA Type:miRNA
Chromosome:chr9
Starnd:+
Coordinate:
Start Site(bp):95086064End Site(bp):95086085
External Links:hsa-miR-24-3p



Disease Information

Disease Name:Moyamoya Disease
Disease Category:Nervous System Diseases
MeSH ID:D009072
Type:Diseases Category/Nervous System Diseases
Alias:Progressive Intracranial Occlusive Arteropathy (Moyamoya)//Moyamoya Syndrome//Moya-Moya Disease//Disease, Moya-Moya//Moya Moya Disease//Cerebrovascular Moyamoya Disease//Moyamoya Disease, Primary//Disease, Primary Moyamoya//Moyamoya Diseases, Primary//Primary Moyamoya Disease//Primary Moyamoya Diseases//Moyamoya Disease, Classic//Classic Moyamoya Disease//Disease, Classic Moyamoya//Moyamoya Disease, Secondary//Secondary Moyamoya Disease



Expression Detail

GEO ID:GSE100488
Description:Circulating miRNome profiling in Moyamoya disease-discordant monozygotic twins
Experimental Design:Disease vs Control
Case Disease Type:Moyamoya Disease
Case Disease SubType:NA
Case Sample:Moyamoya Disease
Control Sample:Normal
Number of Case:11
Number of Control:10
Number of Samples:21





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AEN
chr15
88621337
88632281
+
AMOTL2
chr3
134355874
134375479
-
APPL2
chr12
105173297
105236203
-
ARPP19
chr15
52547045
52569883
-
CD74
chr5
150400041
150412929
-
CEP170B
chr14
104865268
104896770
+
CGN
chr1
151510510
151538692
+
CPA4
chr7
130293134
130324180
+
CREG1
chr1
167529117
167553805
-
CYB5B
chr16
69424619
69466264
+
DNAJB6
chr7
157335381
157417439
+
GALNT10
chr5
154190730
154420984
+
GIGYF1
chr7
100679507
100694037
-
PLEKHM1
chr17
45435900
45490749
-
RUBCN
chr3
197668867
197749727
-
STK4
chr20
44966479
45080021
+
TMEM9
chr1
201134772
201171574
-
WDR36
chr5
111091716
111130502
+
GSK3B
chr3
119821323
120094417
-
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000402
chr12
53670403
53671011
+
hsa_circ_0000155
chr1
168007608
168014465
+
hsa_circ_0000733
chr17
1561546
1562030
-
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
A1BG-AS1
chr19
58347718
58355455
+
AC005034.3
chr2
75697583
75697996
+
AC005394.2
chr19
28435388
28727680
-
AC027031.2
chr8
106270144
106272902
+
AC079781.5
chr7
97851688
97972985
-
AC091564.7
chr11
6610883
6616594
-
AL031282.2
chr1
1702736
1737688
-
DIO3OS
chr14
101552221
101560431
-
EBLN3P
chr9
37079645
37090928
+
KCNQ1OT1
chr11
2608328
2699994
-
MCM3AP-AS1
chr21
46229196
46259390
+
MIR22HG
chr17
1711493
1717174
-
MIR497HG
chr17
7015818
7019659
-
NEAT1
chr11
65422774
65445540
+
Display:



Experiment Detail

GEO ID:GSE100488
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL20712
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:291
Sample treatment protocol:Whole blood samples were collected into disodium ethylenediaminotetraacetate tubes, centrifuged (4 °C, 3000 rpm, 30 minutes) immediately for plasma.
RNA Extract protocol:Total RNA was isolated from 200 uL of the pooled plasma using miRNeasy Serum/Plasma Kit (QIAGEN, Hilden, Germany).
RNA library preparation protocol:Cyanine 3-pCp-labeled microRNA was prepared from 2-uL of total RNA isolated from 200-uL of plasma, using Agilent's miRNA Complete Labeling and Hyb Kit (part number 5190-0456).



Reference

PMID:30157848
Title:Circulating miRNome profiling in Moyamoya disease-discordant monozygotic twins and endothelial microRNA expression analysis using iPS cell line
Author:Uchino H, Ito M, Kazumata K, Hama Y, Hamauchi S, Terasaka S, Sasaki H, Houkin K
Journal:BMC Med Genomics. 2018 Aug 29;11(1):72.
Description:we employed a disease discordant monozygotic twin-based study design to unmask potential confounders.